Communiqué de presse
ABX464 inhibits replication of SARS-COV-2 (COVID-19) in reconstituted Human Respiratory Epithelium model
ABX464 IS THE ONLY DRUG CANDIDATE WITH A POTENTIAL TRIPLE ACTION FOR COVID-19 TREATMENT: ANTIVIRAL, ANTIINFLAMMATORY AND TISSUE REPAIR […]